EUCR
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
EUCR
Delisted
EUCR was delisted on the 26th of April, 2023.
38 hedge funds and large institutions have $84.5M invested in Eucrates Biomedical Acquisition Corp. Ordinary Shares in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
Holders
38
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$6.98M | |
| 2 | +$3.75M | |
| 3 | +$562K | |
| 4 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
+$388K |
| 5 |
MSU
Mizuho Securities USA
New York
|
+$192K |
Top Sellers
| 1 | -$3.07M | |
| 2 | -$990K | |
| 3 | -$430K | |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$367K |
| 5 |
Goldman Sachs
New York
|
-$251K |